from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv0558/menH

LFCtreatmentdescriptionclass of inhibitor

-0.175

Amikacinug/mL Amikacintranslation

-0.075

Cap5-10ug/mL Capreomycintranslation

-0.995

Rox10-50 ug/mL Roxithromycintranslation

-0.513

SM2-5 ug/mL Streptomycintranslation

-0.538

Tet5-10 ug/mL Tetracyclinetranslation

-1.592

Rif0.2-5ug/mL Rifampicintranscription

-1.710

Rifp0.1-0.5ug/mL Rifapentinetranscription

-1.086

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

-1.152

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

0.069

CPZ10-50 ug/mL Chlorpromazinerespiration

-0.940

Clofazimine10-13 ug/mL Clofaziminerespiration

-0.494

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

-0.732

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

-1.677

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

-0.018

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

-0.175

Econazole10-24 ug/mL Econazole (azole drug)respiration

0.098

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

0.206

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

0.011

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

0.165

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

-0.279

KCN5-20 ug/mL Potassium cyaniderespiration

0.626

NaN30.2-2 mM Sodium aziderespiration

-0.793

Nigericin50 uM Nigericinrespiration

0.233

TRC10-150 ug/mL Triclosanrespiration

-0.919

TRZ10-25 ug/mL Thioridazinerespiration

-1.233

Valinomycin0.5-10 uM Valinomycinrespiration

-0.482

ZnSO42 mM ZnSO4respiration

0.022

menadione6-10 ug/mL Menadionerespiration

-0.540

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

0.784

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-0.401

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

0.433

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

0.709

NRP_1Non-replicating persistence stage 1dosRassociated

-0.099

Amp0.2mg/mL AmpicillincellWall

0.915

Cephalexin20-100 ug/mL CephalexincellWall

0.227

Cerulenin0.32-5 ug/mL CerulenincellWall

0.168

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

-0.577

EMB10-20 ug/mL EthambutolcellWall

0.292

Eta12-40 ug/mL EthionamidecellWall

0.732

INH0.2-0.4 ug/mL IsoniazidcellWall

-0.560

TLM0.1-0.2 mg/mL ThiolactomycincellWall

0.375

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.089

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

1.399

BZA0.12 mg/mL BenzamidearomaticAmides

1.199

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

0.998

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

-0.907

H2O24 mM hydrogen peroxideDNAdamaging

0.786

Levo10 ug/mL LevofloxacinDNAdamaging

0.897

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

-0.128

Novobiocin10 ug/mL NovobiocinDNAdamaging

0.699

Oflox5-10 ug/mL OfloxacinDNAdamaging

0.642

UVUV-irradiationDNAdamaging

-1.808

ARP41-4 ug/mL Antitubercular compound ARP4?

0.069

Antimycin12.5-50 ug/mL Antimycin A?

0.162

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

0.109

PA_110-50 ug/mL Antitubercular compound PA-1?

-0.036

PA_2110-50 ug/mL Antitubercular compound PA-21?

0.707

PA8240.2-2 ug/mL PA-824?

0.257

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

0.564

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

-0.565

Verapamil50 uM Verapamil?

0.773

mercaptoethanol2 mM 2-Mercaptoethanol?

-0.282

methoxatin10-20 ug/mL Methoxatin?